Insider Trading activities of Mirati Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirati Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mirati Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Mirati Therapeutics, Inc. since 2005. The reporting company's ticker symbol is MRTX. The reporting company's CIK number is 1576263.
The total value of stock buying since 2005 is $58,462,600.
The total value of stock sales since 2005 is $13,114,036.
The total value of stock option exercises since 2005 is $792,505.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Mirati Therapeutics, Inc. (MRTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 4,000 $56,000 4,000 $34,000
2017-09 0 $0 770 $9,240 0 $0
2017-01 1,174,780 $6,530,727 0 $0 0 $0
2016-06 396,902 $3,893,442 999,358 $9,418,556 0 $0
2016-03 25,414 $491,109 0 $0 0 $0
2016-01 0 $0 10,000 $259,210 17,542 $167,638
2015-09 195,000 $8,775,000 0 $0 0 $0
2015-05 0 $0 4,750 $133,337 4,750 $82,697
2015-03 0 $0 6,000 $153,570 18,666 $250,996
2015-02 100,000 $2,000,000 4,750 $108,823 3,500 $29,750
2015-01 975,000 $19,500,000 0 $0 0 $0
2014-12 0 $0 0 $0 2,500 $21,250
2014-07 0 $0 5,000 $100,200 11,778 $99,995
2014-06 0 $0 102,332 $2,272,250 0 $0
2014-03 0 $0 0 $0 300 $4,284
2014-02 0 $0 0 $0 11,778 $99,995
2013-12 0 $0 0 $0 200 $1,900
2013-11 5,000 $84,820 0 $0 0 $0
2013-10 982,143 $17,187,502 0 $0 0 $0
2013-09 0 $0 36,898 $602,850 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Mirati Therapeutics, Inc. insiders (MRTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-04 Christensen Jamie (SVP, Chief Science Officer) Sale 4,000 14.00 56,000
2017-10-04 Christensen Jamie (SVP, Chief Science Officer) Option Ex 4,000 8.50 34,000
2017-09-15 Christensen Jamie (SVP, Chief Science Officer) Sale 770 12.00 9,240
2017-01-26 Braslyn Ltd. (10% Owner) Buy 48,169 5.45 262,280
2017-01-25 Braslyn Ltd. (10% Owner) Buy 30,600 5.42 165,852
2017-01-24 Braslyn Ltd. (10% Owner) Buy 27,682 5.32 147,268
2017-01-23 Braslyn Ltd. (10% Owner) Buy 19,251 5.27 101,452
2017-01-20 Braslyn Ltd. (10% Owner) Buy 23,873 5.42 129,391
2017-01-19 Braslyn Ltd. (10% Owner) Buy 21,085 5.48 115,545
2017-01-18 Braslyn Ltd. (10% Owner) Buy 16,200 5.50 89,100
2017-01-17 Braslyn Ltd. (10% Owner) Buy 17,800 5.50 97,900
2017-01-13 Braslyn Ltd. (10% Owner) Buy 52,311 5.49 287,187
2017-01-12 Braslyn Ltd. (10% Owner) Buy 49,776 5.50 273,768
2017-01-06 Braslyn Ltd. (10% Owner) Buy 581,870 5.60 3,258,472
2017-01-06 Fuglesang Christopher (10% Owner) Buy 286,163 5.60 1,602,512
2016-06-14 Baum Charles M (PRESIDENT & CEO) Buy 20,000 7.05 141,080
2016-06-09 Baker Bros. Advisors (gp) Llc (10% Owner) Sale 545,058 9.48 5,166,604
2016-06-08 Baker Bros. Advisors (gp) Llc (10% Owner) Sale 158,100 9.21 1,456,417
2016-06-07 Braslyn Ltd. (10% Owner) Buy 161,751 9.49 1,535,016
2016-06-07 Baker Bros. Advisors (gp) Llc (10% Owner) Sale 296,200 9.44 2,795,535
2016-06-06 Braslyn Ltd. (10% Owner) Buy 215,151 10.31 2,217,346
2016-03-29 Braslyn Ltd. (10% Owner) Buy 3,400 19.09 64,906
2016-03-28 Braslyn Ltd. (10% Owner) Buy 300 19.48 5,844
2016-03-24 Braslyn Ltd. (10% Owner) Buy 20,548 19.36 397,809
2016-03-18 Braslyn Ltd. (10% Owner) Buy 1,166 19.34 22,550
2016-01-15 Gergen Mark J (Executive VP, COO) Sale 10,000 25.92 259,210
2016-01-15 Gergen Mark J (Executive VP, COO) Option Ex 15,000 8.50 127,500
2016-01-13 Chen Isan (Sr.Vice President, Chief Medi) Option Ex 2,542 15.79 40,138
2015-09-16 Baker Bros. Advisors (gp) Llc (10% Owner) Buy 150,000 45.00 6,750,000
2015-09-16 Mva Investors, Llc (10% Owner) Buy 45,000 45.00 2,025,000
2015-05-26 Christensen Jamie (SVP & Chief Scientific Officer) Sale 4,750 28.07 133,337
2015-05-26 Christensen Jamie (SVP & Chief Scientific Officer) Option Ex 4,750 17.41 82,697
2015-03-09 Chen Isan (Chief Medical & Dev't Officer) Option Ex 12,666 15.79 199,996
2015-03-05 Christensen Jamie (SVP & Chief Scientific Officer) Sale 6,000 25.59 153,570
2015-03-05 Christensen Jamie (SVP & Chief Scientific Officer) Option Ex 6,000 8.50 51,000
2015-02-19 Christensen Jamie (SVP & Chief Scientific Officer) Sale 3,100 23.02 71,377
2015-02-19 Christensen Jamie (SVP & Chief Scientific Officer) Option Ex 3,100 8.50 26,350
2015-02-17 Christensen Jamie (SVP & Chief Scientific Officer) Sale 1,650 22.70 37,446
2015-02-17 Christensen Jamie (SVP & Chief Scientific Officer) Option Ex 400 8.50 3,400
2015-02-03 Isaly Samuel D Buy 100,000 20.00 2,000,000
2015-01-29 667, L.p. (10% Owner) Buy 425,000 20.00 8,500,000
2015-01-29 Mva Investors, Llc (10% Owner) Buy 550,000 20.00 11,000,000
2014-12-05 Christensen Jamie (SVP & Chief Scientific Officer) Option Ex 2,500 8.50 21,250
2014-07-25 Baum Charles M (President and CEO) Option Ex 11,778 8.49 99,995
2014-07-01 Isaly Samuel D Sale 5,000 20.04 100,200
2014-06-30 Isaly Samuel D Sale 14,000 20.72 290,080
2014-06-27 Isaly Samuel D Sale 88,332 22.44 1,982,170
2014-03-04 Godbout Martin (Director) Option Ex 300 14.28 4,284
2014-02-19 Baum Charles M (President and CEO) Option Ex 11,778 8.49 99,995
2013-12-16 Godbout Martin (Director) Option Ex 200 9.50 1,900
2013-11-26 Baum Charles M (President and CEO) Buy 5,000 16.96 84,820
2013-10-29 Isaly Samuel D Buy 125,000 17.50 2,187,500
2013-10-24 Baker Bros. Advisors Lp (10% Owner) Buy 400,000 17.50 7,000,000
2013-10-24 Tang Capital Management Llc (10% Owner) Buy 57,143 17.50 1,000,002
2013-10-24 Lewis Joseph (10% Owner) Buy 400,000 17.50 7,000,000
2013-09-20 Tang Capital Management Llc (10% Owner) Sale 4,316 16.25 70,135
2013-09-19 Tang Capital Management Llc (10% Owner) Sale 32,582 16.35 532,715

Insider trading activities including stock purchases, stock sales, and option exercises of MRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mirati Therapeutics, Inc. (symbol MRTX, CIK number 1576263) see the Securities and Exchange Commission (SEC) website.